Globally, tuberculosis (TB) is the leading cause of death among people living with HIV (PLHIV). According to the World Health Organization’s 2020 Global Tuberculosis Report, 815,000 PLHIV developed active TB, and 208,000 PLHIV died from TB in 2019. As the world fights the COVID-19 pandemic through social distancing and lock downs, reports from STOP TB Partnership (STOP TB) indicate a significant reduction of TB case notification that can potentially reverse progress towards TB treatment and prevention. This two-pager provides an overview on the supply chain role of TB treatment regimens to reduce the pill burden on TB/HIV patients.
Fact Sheet: Supporting the Scale Up of Tuberculosis Preventive Treatment (TPT) in PEPFAR-Supported Countries
March 23, 2021
March 29, 2021